- Home
- TR vs APGE Comparison
TR vs APGE Comparison
Compare TR & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- APGE
- Stock Information
- Founded
- TR 1896
- APGE 2022
- Country
- TR United States
- APGE United States
- Employees
- TR N/A
- APGE N/A
- Industry
- TR Specialty Foods
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TR Consumer Staples
- APGE Health Care
- Exchange
- TR Nasdaq
- APGE Nasdaq
- Market Cap
- TR 2.5B
- APGE 2.6B
- IPO Year
- TR N/A
- APGE 2023
- Fundamental
- Price
- TR $37.97
- APGE $39.31
- Analyst Decision
- TR
- APGE Strong Buy
- Analyst Count
- TR 0
- APGE 4
- Target Price
- TR N/A
- APGE $97.50
- AVG Volume (30 Days)
- TR 345.8K
- APGE 1.3M
- Earning Date
- TR 08-07-2025
- APGE 08-11-2025
- Dividend Yield
- TR 0.96%
- APGE N/A
- EPS Growth
- TR N/A
- APGE N/A
- EPS
- TR 1.21
- APGE N/A
- Revenue
- TR $718,497,000.00
- APGE N/A
- Revenue This Year
- TR N/A
- APGE N/A
- Revenue Next Year
- TR N/A
- APGE $743.14
- P/E Ratio
- TR $31.28
- APGE N/A
- Revenue Growth
- TR N/A
- APGE N/A
- 52 Week Low
- TR $26.78
- APGE $26.20
- 52 Week High
- TR $38.27
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- TR 68.15
- APGE 47.86
- Support Level
- TR $34.59
- APGE $37.05
- Resistance Level
- TR $35.71
- APGE $39.47
- Average True Range (ATR)
- TR 1.06
- APGE 2.87
- MACD
- TR 0.33
- APGE -0.38
- Stochastic Oscillator
- TR 95.20
- APGE 30.00
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.